| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |